Medicare Enrolled
Dr. Viyada Sarabanchong, MD
Gastroenterology · Pomona, NY
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Sarabanchong from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Sarabanchong?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Sarabanchong
Dr. Viyada Sarabanchong is a gastroenterology specialist in Pomona, NY, with 19 years of NPI registration. Based on federal Medicare data, Dr. Sarabanchong performed 972 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Sarabanchong received a total of $7,780 from 45 pharmaceutical and/or device companies across 376 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Sarabanchong is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years of NPI registration
▲ Top 26% volume in NY
$7,780 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗972
Medicare services
Top 26% in NY for gastroenterology
Not available
Unique patients (not deduplicated)
$170
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
298 | $112 | $175 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
153 | $73 | $150 |
| Upper GI endoscopy with biopsy A procedure to collect tissue samples from the esophagus, stomach, or upper small intestine using a flexible tube with a camera. The samples are examined to check for abnormalities. |
95 | $290 | $950 |
| Colonoscopy A diagnostic exam of the large bowel using a flexible endoscope to visualize the interior of the colon. |
91 | $295 | $1,000 |
| Colonoscopy with biopsy A procedure to collect tissue samples from the large intestine using a flexible tube with a camera. The samples are examined to check for abnormalities or disease. |
72 | $277 | $1,106 |
| Initial hospital admission, low complexity Initial hospital inpatient or observation care for a new patient involving straightforward or low-level medical decision making, with at least 40 minutes total time on the date of the encounter. |
65 | $74 | $200 |
| Colon polyp removal with endoscopic snare This procedure removes polyps or growths from the large bowel using a flexible tube with a camera and a wire loop tool. The snare is used to cut off the growths during the examination. |
61 | $454 | $1,500 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
51 | $137 | $249 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
33 | $76 | $150 |
| Urine pregnancy test A laboratory test performed on a urine sample to detect the presence of human chorionic gonadotropin (hCG), a hormone produced during pregnancy. |
25 | $8 | $25 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
17 | $139 | $250 |
| Injection beneath large bowel lining via endoscope A flexible endoscope is used to inject medication or fluid beneath the lining of the large intestine. |
11 | $138 | $1,300 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$7,780
Total received (2018-2024)
Avg $1,111/year across 7 years
Top 25% in NY for gastroenterology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
45
Companies
376
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,764
2023
$1,724
2022
$1,458
2021
$1,067
2020
$554
2019
$419
2018
$794
Payments by company (2024)
ABBVIE INC.
$310
Takeda Pharmaceuticals U.S.A., Inc.
$203
Boston Scientific Corporation
$171
Intercept Pharmaceuticals, Inc.
$150
Madrigal Pharmaceuticals
$131
Gilead Sciences, Inc.
$120
Ardelyx, Inc.
$94
Janssen Biotech, Inc.
$91
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$82
GENZYME CORPORATION
$73
Lilly USA, LLC
$47
PFIZER INC.
$41
Boehringer Ingelheim Pharmaceuticals, Inc.
$39
Phathom Pharmaceuticals, Inc.
$32
Celgene Corporation
$31
IRONWOOD PHARMACEUTICALS, INC
$23
Blueprint Medicines Corporation
$20
Merck Sharp & Dohme LLC
$19
AIMMUNE THERAPEUTICS, INC.
$18
Ferring Pharmaceuticals Inc.
$17
Celltrion USA Inc.
$16
Exact Sciences Corporation
$15
Medtronic, Inc.
$13
Meridian Bioscience Inc.
$8
Top 3 companies account for 38.8% of 2024 payments
All-time payments by company (2018-2024) ›
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$910
Gilead Sciences, Inc.
$740
Janssen Biotech, Inc.
$717
Takeda Pharmaceuticals U.S.A., Inc.
$646
ABBVIE INC.
$634
AbbVie Inc.
$564
PFIZER INC.
$418
GENZYME CORPORATION
$369
Medtronic, Inc.
$250
Synergy Pharmaceuticals Inc
$185
Boston Scientific Corporation
$171
Intercept Pharmaceuticals, Inc.
$162
Celgene Corporation
$158
Ferring Pharmaceuticals Inc.
$141
Ironwood Pharmaceuticals, Inc
$139
Ardelyx, Inc.
$138
Madrigal Pharmaceuticals
$131
E.R. Squibb & Sons, L.L.C.
$124
Merck Sharp & Dohme LLC
$111
AbbVie, Inc.
$104
Allergan Inc.
$101
Regeneron Healthcare Solutions, Inc.
$93
QOL Medical, LLC
$73
Daiichi Sankyo Inc.
$64
Boehringer Ingelheim Pharmaceuticals, Inc.
$63
Nestle HealthCare Nutrition Inc.
$54
RedHill Biopharma Inc.
$52
Fresenius Kabi USA, LLC
$48
Lilly USA, LLC
$47
Alfasigma USA, Inc.
$41
Janssen Scientific Affairs, LLC
$40
Concordia Pharmaceuticals Inc.
$33
Merck Sharp & Dohme Corporation
$33
Phathom Pharmaceuticals, Inc.
$32
Organon LLC
$29
NESTLE HEALTHCARE NUTRITION INC.
$27
IRONWOOD PHARMACEUTICALS, INC
$23
Blueprint Medicines Corporation
$20
AIMMUNE THERAPEUTICS, INC.
$18
Celltrion USA Inc.
$16
Exact Sciences Corporation
$15
Braintree Laboratories, Inc.
$14
AstraZeneca Pharmaceuticals LP
$13
Endo Pharmaceuticals Inc.
$11
Meridian Bioscience Inc.
$8
Top 3 companies account for 30.4% of all-time payments
Associated products mentioned in payments ›
AYVAKIT · Amitiza · CIMZIA · CLENPIQ · CREON · CYLTEZO · Cologuard Collection Kit · Creon · DIFICID · DONNATAL · DUPIXENT · ENTYVIO · EOHILIA · GATTEX · GI GENIUS · HUMIRA · Humira · IBSRELA · INFLECTRA · INJECTAFER · INTERSTIM · LINZESS · Linzess · MOTEGRITY · MOVANTIK · Motegrity · NASCOBAL · OCALIVA · OMVOH · REBYOTA · RELISTOR · REMICADE · RENFLEXIS · RESMETIROM · RINVOQ · SIMPONI · SKYRIZI · STELARA · SUPREP · Sucraid · TREMFYA · TRULANCE · Talicia · Trulance · UCERIS · VIBERZI · VOQUEZNA · VOWST · Vemlidy · WATCHMAN FLX · XELJANZ · XIFAXAN · ZENPEP · ZEPOSIA · ZYMFENTRA · Zelnorm
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Gastroenterologists in nearby ZIP areas
322
County median income
$110,631
Nearest hospital to ZIP centroid (approximate)
GOOD SAMARITAN HOSPITAL OF SUFFERN
4.0 mi
4.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Sarabanchong is a clinical cardiology specialist, with above-average Medicare volume (top 26% in NY), with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Sarabanchong experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Sarabanchong performed 298 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Sarabanchong receive payments from pharmaceutical companies?
Yes. Dr. Sarabanchong received a total of $7,780 from 45 companies across 376 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Sarabanchong's costs compare to other gastroenterologists in Pomona?
Dr. Sarabanchong's average Medicare payment per service is $170. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Sarabanchong) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Gastroenterology
Common procedures, typical costs, and what industry payments mean in gastroenterology.
Same specialty & city
Gastroenterologists in Pomona
Browse gastroenterologists in Pomona ranked by procedure volume and transparency data.
Highest volume
Top Gastroenterologists in NY
Gastroenterologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Gastroenterologists in NY
Which NY gastroenterologists receive the most from drug and device companies.
By company
Salix Pharmaceuticals, a division of Bausch Health US, LLC Payments to Doctors
See all physicians who received payments from Salix Pharmaceuticals, a division of Bausch Health US, LLC.
By company
Gilead Sciences, Inc. Payments to Doctors
See all physicians who received payments from Gilead Sciences, Inc.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology